Common use of Grant of Option Clause in Contracts

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] (the “Grant Date”) to [ ], an employee, consultant or director of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 par value per share, of the Company (“Common Stock”) at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2015 Stock Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 par value per share, of the Company (“Common Stock”) ), at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Blackboard Inc., a Delaware corporation (the “Company”), on [ , 20 [Date] (the “Grant Date”) to [ [Name], an employee, consultant or director of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2004 Stock Incentive Plan (the “Plan”), a total of [ [Number] shares (the “Shares”) of common stock, $0.0001 0.01 par value per share, of the Company (“Common Stock”) at $[ [Price] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the tenth anniversary of the Grant Date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineCivitas Therapeutics, Inc., a Delaware corporation (the “Company”), on [ , 20 [—] (the “Grant Date”) to [ [—], an employee, consultant or director of the Company individual (the “Participant”)) [—], of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2010 Stock Incentive Plan (the “Plan”), a total of [ [—] shares (the “Shares”) of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) at $[ [—] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] the ten-year anniversary of the [date is ten years minus one day from grant date—] (the “Final Exercise Date”). [—]. It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineTetraphase Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on , 200[ , 20 ] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2006 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) at a price of $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineDurata Therapeutics, Inc., a Delaware corporation (the “Company”), on [ , 20 ] 2012 (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2012 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 0.01 par value per share, of the Company (“Common Stock”) at $[ ] per Share. Share.1 Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the “Final Exercise Date”). Date”).2 It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineKolltan Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on [ February 27, 20 ] 2009 (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock 2008 Equity Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stockCommon Stock, $0.0001 .001 par value per sharevalue, of the Company (“Common Stock”) at $[ ] 0.10 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, ,” as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineXxxxxx Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on [ September 15, 20 ] 2016, (the “Grant Date”) to [ ]Xxxxxx Xxxxxxxx, an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2011 Stock Incentive Plan (the “Plan”), a total of [ ] 801,540 shares (the “Shares”) of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) at $[ ] 0.38 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ September 15, 20 ] [date is ten years minus one day from grant date] 2026 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement Agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), Company on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this Agreement (the “ParticipantNotice of Grant”), ) to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock 2016 Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of common stockGrant of Class A Common Stock, $0.0001 0.01 par value per share, of the Company (“Common Stock”) at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement Agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineXxxx.xxx, Inc., a Delaware corporation (the “Company”), on [ , 20 ] «Grant_Date» (the “Grant Date”) to [ ], «First» «Last» an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2006 Stock Incentive Plan (the “Plan”), a total of [ ] «Shares» shares (the “Shares”) of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) at $[ ] «Price» per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [the date is ten years minus one day from grant date] after the date immediately prior to the Grant Date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock 2017 Equity Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) ), at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 par value per share, of the Company (“Common Stock”) at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicinePTC Therapeutics, Inc., a Delaware corporation (the “Company”), on [ ], 20 ] 2013 (the “Grant Date”) to [ ], an employee, consultant or director of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 [ ] par value per share, of the Company (“Common Stock”) at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ March 4, 20 ] [date is ten years minus one day from grant date] 2023 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2016 Stock Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) ), at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Blackboard Inc., a Delaware corporation (the “Company”), on [ [Date], 20 ] (the “Grant Date”) to [ [Name], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2004 Stock Incentive Plan (the “Plan”), a total of [ [Number] shares (the “Shares”) of common stock, $0.0001 0.01 par value per share, of the Company (“Common Stock”) at $[ [Price] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the tenth anniversary of the Grant Date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), ) to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 par value per share, of the Company (“Common Stock”) at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2015 Stock Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) ), at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineAVEO Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on , 20[ , 20 ] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2010 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 .001 par value per share, of the Company (“Common Stock”) at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineAileron Therapeutics, Inc., a Delaware corporation (the “Company”), on [ , 20 ] 200 (the “Grant Date”) to [ ]Xxxxxx X. Xxxxxxx III, an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2006 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) at $[ ] an exercise price of $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the tenth anniversary of the Grant Date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineDemandware, Inc., a Delaware corporation (the “Company”), on [ , 20 ] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company or one of its subsidiaries or affiliates (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2012 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 0.01 par value per share, of the Company (“Common Stock”) at $[ ] $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Cerulean Pharma Inc., a Delaware corporation (the “Company”), on [ , 20 ] 201 (the “Grant Date”) to [ ], [an employee, consultant or director ] [a consultant] of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2007 Stock Incentive Plan Plan, as amended (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 par value per share, of the Company (“Common Stock”) at $[ ] $ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [the date is ten years minus one day from grant date] after the date immediately prior to the Grant Date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineNestor, Inc., Inc. a Delaware corporation (the “"Company”"), on [ March 20, 20 ] 0005 (the “"Grant Date”") to [ ]Tadas A. Eikinas, an employee, consultant or director employee of the Company (the “"Participant”"), of an option to xx xx xxxxxx xx purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 's 2004 Stock Incentive Plan (the “"Plan”"), a total of [ ] 30,000 shares (the “"Shares”") of common stock, $0.0001 .01 par value per share, of the Company (“"Common Stock”") at $[ ] 5.95 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ March 29, 20 ] [date is ten years minus one day from grant date] 2013 (the “"Final Exercise Date”"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “"Code”"), to the extent permitted by the Code. Except as otherwise indicated by the context, the term “"Participant”", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineXxxxxx, Inc., Inc. a Delaware corporation (the “Company”), on [ September 7, 20 ] 2006 (the “Grant Date”) to [ ]Xxxxx X. Xxxxxxx, an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2004 Stock Incentive Plan (the “Plan”), a total of [ ] 25,000 shares (the “Shares”) of common stock, $0.0001 .01 par value per share, of the Company (“Common Stock”) at $[ ] 2.93 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ September 7, 20 ] [date is ten years minus one day from grant date] 2014 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock 2015 Equity Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 par value per share, of the Company (“Common Stock”) ), at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineConstant Contact, Inc., a Delaware corporation (the “Company”), on [ January 24, 20 ] 2011 (the “Grant Date”) to [ [_________], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2007 Stock Incentive Plan (the “Plan”), a total of [ [_________] shares (the “Shares”) of common stock, $0.0001 0.01 par value per share, of the Company (“Common Stock”) at $[ ] 28.27 per Share. Unless earlier terminatedterminated or unless this option expires earlier pursuant to Section 2(a) below, this option shall expire at 5:00 p.m., Eastern time, on [ January 24, 20 ] [date is ten years minus one day from grant date] 2021 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”), to the fullest extent permitted thereby. Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineArgos Therapeutics, Inc., a Delaware corporation (the “Company”), on [ ], 20 20[ ] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2011 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) at an exercise price of $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ], 20 ] 20[ ][date is ten 10 years minus one day from grant datefollowing the Grant Date] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineAileron Therapeutics, Inc., a Delaware corporation (the “Company”), on , 200[ , 20 ] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2006 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) at an exercise price of $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the tenth anniversary of the Grant Date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineAchillion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on [ August 1, 20 ] 2005 (the “Grant Date”) to [ ]Xxxxxx Xxxxxxxxx, an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 1998 Stock Incentive Option Plan (the “Plan”), a total of [ ] 15,000 shares (the “Shares”) of common stock, $0.0001 .001 par value per share, of the Company (“Common Stock”) at $[ ] 0.20 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m.on August 1, Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] 2015 (the “Final Exercise Date”). For purposes of this Agreement, the “Vesting Commencement Date” shall be August 1, 2005. It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, amended and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineCEVA, Inc., a Delaware corporation (the “Company”), on , 200[ , 20 ] (the “Grant Date”) to [ ], an employee, consultant or a director of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2000 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern timeTime, on [ June 30, 20 ] [date is ten years minus one day from grant date] (the “Final Exercise Date”). Unless otherwise defined herein, capitalized terms shall have the meaning ascribed to them in the Plan. It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock 2016 Equity Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 par value per share, of the Company (“Common Stock”) ), at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Open Solutions Inc., a Delaware corporation (the “"Company”"), on [ _____, 20 ] 200__ (the “"Grant Date”") to [ ]______________, [an employee, consultant or director /a consultant/a director] of the Company (the “"Participant”"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 's 2003 Stock Incentive Plan (the “"Plan”"), a total of [ ] _____shares (the “"Shares”") of common stock, $0.0001 0.01 par value per share, of the Company (“"Common Stock”") at $[ ] _____ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ _______[insert date 9 years, 20 ] [date is ten years minus one day from grant date364 days after Grant Date] (the “"Final Exercise Date”"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “"Code”"). Except as otherwise indicated by the context, the term “"Participant”, ," as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2023 Stock Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 0.00001 par value per share, of the Company (“Common Stock”) ), at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the The option evidenced by this agreement shall is not intended to be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc.MicroStrategy Incorporated, a Delaware corporation (the “CompanyMicroStrategy”), on [ September 5, 20 ] 2013 (the “Grant Date”) to [ ], an employee, consultant or director of the Company Xxxx Xxxx (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the CompanyMicroStrategy’s 2013 Stock Incentive Plan (the “Plan”), a total of [ ] 100,000 shares (the “Shares”) of class A common stock, $0.0001 0.001 par value per share, of the Company MicroStrategy (“Common Stock”) at $[ ] 92.84 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ September 5, 20 ] [date is ten years minus one day from grant date] 2023 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineBioSphere Medical, Inc., a Delaware corporation (the “Company”), on [ , 20 ] (the “Grant Date”) to [ , an [employee], an employee[consultant], consultant or director [director] of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 1997 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 .01 par value per share, of the Company (“Common Stock”) at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is generally ten years minus one day from grant datethe date of grant] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineBoston Life Sciences, Inc., a Delaware corporation (the “"Company”"), on [ January 6, 20 ] 2006 (the “"Grant Date”") to [ ]Xxxx X. Xxxxxx, an employee, consultant or director executive officer of the Company (the “"Participant”"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 's 2005 Stock Incentive Plan (the “"Plan”"), a total of [ ] 225,000 shares (the “"Shares”") of common stock, $0.0001 0.01 par value per share, of the Company (“"Common Stock”") at $[ ] 2.50 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ January 5, 20 ] [date is ten years minus one day from grant date] 2016 (the “"Final Exercise Date”"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “"Code”"). Except as otherwise indicated by the context, the term “"Participant”", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineAlnylam Pharmaceuticals, Inc., a Delaware corporation (the “"Company”"), on ________, 200[ , 20 ] (the “"Grant Date”") to [ [______], an employee, consultant or director employee of the Company (the “"Participant”"), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 's 2004 Stock Incentive Plan (the “"Plan”"), a total of [ [__] shares (the “"Shares”") of common stock, $0.0001 .01 par value per share, of the Company (“"Common Stock”") at $[ [__] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [the date that is ten years minus one day from grant datethe Grant Date] (the “"Final Exercise Date”"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “"Code”"). Except as otherwise indicated by the context, the term “"Participant”", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement (hereinafter, the "Agreement") evidences the grant by Editas MedicineBoston Life Sciences, Inc., a Delaware corporation (the “"Company”"), on [ JULY 18, 20 ] 2005 (the “"Grant Date”") to [ ]XXX XXXX, an employee, consultant or director EMPLOYEE of the Company (the “Participant”"Optionee"), of an option (this "Option") to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock Incentive Plan (the “Plan”)herein, a total of [ ] 300,000 shares (the “"Shares”") of common stock, $0.0001 0.01 par value per share, of the Company (“"Common Stock”") at $[ ] 3.25 per Share. Unless earlier terminated, this option Option shall expire at 5:00 p.m., Eastern time, on [ JULY 17, 20 ] [date is ten years minus one day from grant date] 2015 (the “"Final Exercise Date”"). It is intended that the option Option evidenced by this agreement Agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “"Code”"). Except as otherwise indicated by the context, the term “Participant”"Optionee", as used in this optionOption, shall be deemed to include any person who acquires the right to exercise this option Option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc.CuraGen Corporation, a Delaware corporation (the “Company”), on [ , 20 [DATE] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2007 Stock Incentive Plan (the “Plan”), a total of [ ] (words shares) (# shares) shares (the “Shares”) of common stock, $0.0001 .01 par value per share, of the Company (“Common Stock”) at $[ [PRICE] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ January 24, 20 ] [date is ten years minus one day from grant date] 2018 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2015 Stock Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 0.01 par value per share, of the Company (“Common Stock”) ), at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement Agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2015 Stock Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 0.00001 par value per share, of the Company (“Common Stock”) ), at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineCollaGenex Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on [ ], 20 200[ ] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock 2005 Equity Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 0.01 par value per share, of the Company (“Common Stock”) at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineOclaro, Inc., a Delaware corporation (the “Company”), on [ , 20 ] as of the date of grant (the “Grant Date”) to [ ], an employee, consultant or director the individual listed on the attached Notice of the Company Grant (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Amended and Restated 2004 Stock Incentive Plan (the “Plan”), a total the number of [ ] shares (the “Shares”) of common stock, $0.0001 0.01 par value per share, of the Company (“Common Stock”) at $[ ] the price per Shareshare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern Pacific time, on [ , 20 ] [date is ten years minus one day from grant date] the tenth anniversary of the Grant Date (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineNestor, Inc., Inc. a Delaware corporation (the “"Company”"), on [ October 10, 20 ] 0004 (the “"Grant Date”") to [ ]Nigel P. Hebborn, an employee, consultant or director employee of the Company (the “"Participant”"), of an option to purchaseox xx xxxxxx xx xurchase, in whole or in part, on the terms provided herein and in the Company’s 2013 's 2004 Stock Incentive Plan (the “"Plan”"), a total of [ ] 300,000 shares (the “"Shares”") of common stock, $0.0001 .01 par value per share, of the Company (“"Common Stock”") at $[ ] 4.95 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ October 13, 20 ] [date is ten years minus one day from grant date] 2012 (the “"Final Exercise Date”"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “"Code”"), to the extent permitted by the Code. Except as otherwise indicated by the context, the term “"Participant”", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicinethe Company, Inc., a Delaware corporation (the “Company”), on [ , 20 ] grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), ) to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock 2016 Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineCambridge Heart, Inc., a Delaware corporation (the “Company”), in lieu of a 2009 cash bonus, on [ March , 20 ] 2010 (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2001 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 .001 par value per share, of the Company (“Common Stock”) at $[ ] $ per ShareShare (the “Option”). Unless earlier terminated, this option Option shall expire at 5:00 p.m.on March , Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] 2020 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”), to the maximum extent permitted by the Code. Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2014 Stock Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 par value per share, of the Company (“Common Stock”) ), at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement (this “Agreement”) evidences the grant by Editas Medicine, Inc.Penwest Pharmaceuticals Co., a Delaware Washington corporation (the “Company”), on [ June 21, 20 ] 2004 (the “Grant Date”) to [ ]Axxx X. Xxxxxx, an employee, consultant or director employee of the Company (the “ParticipantEmployee”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock Incentive Plan (the “Plan”)herein, a total of [ ] 100,000 shares (the “Shares”) of common stock, $0.0001 .001 par value per share, of the Company (“Common Stock”) at an exercise price of $[ ] 11.06 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ June 22, 20 ] [date is ten years minus one day from grant date] 2014 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement Agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “ParticipantEmployee”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineNitroSecurity, Inc., a Delaware corporation (the “Company”), on [ February 21, 20 ] 2005 (the “Grant Date”) to [ ]Sxxx XxXxxxx, an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2005 Stock Incentive Plan (the “Plan”), a total of [ ] 100,000 shares (the “Shares”) of common stock, $0.0001 0.01 par value per share, of the Company (“Common Stock”) at $[ ] 0.15 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ February 20, 20 ] [date is ten years minus one day from grant date] 2015 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, ,” as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineNestor, Inc., Inc. a Delaware corporation (the “"Company”"), on [ October 10, 20 ] 0004 (the “"Grant Date”") to [ ]Nigel P. Hebborn, an employee, consultant or director employee of the Company (the “"Participant”"), of an option to purchaseox xx xxxxxx xx xurchase, in whole or in part, on the terms provided herein and in the Company’s 2013 's 2004 Stock Incentive Plan (the “"Plan”"), a total of [ ] 300,000 shares (the “"Shares”") of common stock, $0.0001 .01 par value per share, of the Company (“"Common Stock”") at $[ ] 4.95 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ October 12, 20 ] [date is ten years minus one day from grant date] 2014 (the “"Final Exercise Date”"). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “"Code”"), to the extent permitted by the Code. Except as otherwise indicated by the context, the term “"Participant”", as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineArgos Therapeutics, Inc., a Delaware corporation (the “Company”), on [ ], 20 20[__] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2014 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) at an exercise price of $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ ], 20 ] [date is ten 20[__][10 years minus one day from grant datefollowing the Grant Date] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineSkyworks Solutions, Inc., a Delaware corporation (the “Company”), on , 200[ , 20 ] (the “Grant Date”) to [ ], an employee, consultant or director a member of the Board of Directors of the Company (the “ParticipantDirector”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock 2008 Director Long-Term Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 .25 par value per share, of the Company (“Common Stock”) at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] ][date is ten years minus one day from grant date10 YEARS FROM DATE OF GRANT] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “ParticipantDirector”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicinePTC Therapeutics, Inc., a Delaware corporation (the “Company”), on [ , 20 [·] (the “Grant Date”) to [ [·], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock Long-Term Incentive Plan (the “Plan”), a total of [ [·] shares (the “Shares”) of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) at $[ [·] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date·] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”)) to the maximum extent permitted by applicable federal tax laws. Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineSpring Bank Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on [ , 20 ] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2014 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 par value per share, of the Company (“Common Stock”) at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2018 Stock Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) ), at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc., a Delaware corporation (the “Company”), on [ , 20 ] the grant date (the “Grant Date”) to [ ], an employee, consultant or director set forth in the Notice of the Company Grant that forms part of this agreement (the “ParticipantNotice of Grant”), to the Participant of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2017 Stock Incentive Plan (the “Plan”), a total the number of [ ] shares (Shares set forth in the “Shares”) Notice of Grant of common stock, $0.0001 $ par value per share, of the Company (“Common Stock”) ), at $[ ] the exercise price per ShareShare set forth in the Notice of Grant. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] the Final Exercise Date set forth in the Notice of Grant (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas Medicine, Inc.Abraxas Petroleum Corporation, a Delaware Nevada corporation (the “Company”), on [ , 20 ] _________ (the “Grant Date”) to [ ]______________, an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock 2005 Employee Long-Term Equity Incentive Plan (the “Plan”), a total of [ ] ________________ shares (the “Shares”) of common stock, $0.0001 par value $.01 per share, of the Company (“Common Stock”) at $[ ] _______ per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] in accordance with Section 3(c) below (the “Final Exercise Date”). Except as otherwise defined in this Agreement, capitalized terms used herein shall have the meaning set forth in the Plan. It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, amended and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineTransMedics, Inc., a Delaware corporation (the “Company”), on , 200[ , 20 ] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2004 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 par value per share, of the Company (“Common Stock”) at $[ [insert FMV] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 [insert date immediately prior to tenth anniversary of Grant Date] [date is ten years minus one day from grant date] (( the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineIdera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), on , 201[ , 20 ] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Stock Incentive Plan (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 0.001 par value per share, of the Company (“Common Stock”) at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineCuris, Inc., a Delaware corporation (the “Company”), on , 201[ , 20 ] (the “Grant Date”) to [ ], an employee, consultant or director employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 Amended and Restated 2010 Stock Incentive Plan Plan, as amended (the “Plan”), a total of [ ] shares (the “Shares”) of common stock, $0.0001 0.01 par value per share, of the Company (“Common Stock”) at $[ ] per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ , 20 ] [date is ten years minus one day from grant date_______] (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineAchillion Pharmaceuticals, Inc., Inc. a Delaware corporation (the “Company”), on [ December 19, 20 ] 2006 (the “Grant Date”) to [ ]Xxxxxxx Xxxx, an employee, consultant or a director of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2006 Stock Incentive Plan (the “Plan”), a total of [ ] 15,000 shares (the “Shares”) of common stock, $0.0001 .001 par value per share, of the Company (“Common Stock”) at $[ ] 14.75 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ December 18, 20 ] [date is ten years minus one day from grant date] 2016 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.

Grant of Option. This agreement evidences the grant by Editas MedicineAchillion Pharmaceuticals, Inc., Inc. a Delaware corporation (the “Company”), on [ December 19, 20 ] 2006 (the “Grant Date”) to [ ]Xxxxx Xxxxxx, an employee, consultant or a director of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2013 2006 Stock Incentive Plan (the “Plan”), a total of [ ] 15,000 shares (the “Shares”) of common stock, $0.0001 .001 par value per share, of the Company (“Common Stock”) at $[ ] 14.75 per Share. Unless earlier terminated, this option shall expire at 5:00 p.m., Eastern time, on [ December 18, 20 ] [date is ten years minus one day from grant date] 2016 (the “Final Exercise Date”). It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to exercise this option validly under its terms.